Comparison of different second line treatments for metastatic pancreatic cancer: a systematic review and network meta-analysis

BACKGROUND: In metastatic pancreatic ductal adenocarcinoma (mPDAC), first line treatment options usually include combination regimens of folinic acid, 5-fluorouracil (5-FU), irinotecan, and oxaliplatin (FOLFIRINOX or mFOLFIRINOX) or gemcitabine based regimens such as in combination with albumin-boun...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrelli, Fausto, Parisi, Alessandro, Tomasello, Gianluca, Mini, Emanuele, Arru, Marcella, Russo, Alessandro, Garrone, Ornella, Khakoo, Shelize, Ardito, Raffaele, Ghidini, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278314/
https://www.ncbi.nlm.nih.gov/pubmed/37337148
http://dx.doi.org/10.1186/s12876-023-02853-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278314/
https://www.ncbi.nlm.nih.gov/pubmed/37337148
http://dx.doi.org/10.1186/s12876-023-02853-w

Ejemplares similares